|
ChemDiv built an impressive track record over the past twenty years and is proud to have worked with over a thousand pharmaceutical, biotech and academic partners on a range of drug discovery research projects with varying models of financial and scientific collaboration.
These projects included discovery and optimization of small molecules for a range of therapeutic targets and pathways in oncology, inflammation and CNS; the VIP discovery chemistry technology access program; Focused Diversity libraries for biological screening, HTS collaborations, and integrated discovery and development projects. We have developed and executed pipeline/portfolio programs encompassing multiple targets and therapeutic indications for our partners; as well as providing preclinical, translational and clinical development services on a cost-effective, time-efficient basis.
Our experience and successes across the full range of discovery and development challenges has shaped our focus on 'Fail Fast / Fast Forward" strategy and has made us experts in conducting ultra-lean operations. ChemDiv consistently delivers the highest value for R&D investments.
ChemDiv's Partners include
|
